Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Associations Between Circulating N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) and Adiponectin Concentrations Depend on Obesity Level in Female Adolescents: Gender Dimorphic Findings
Hormone and Metabolic Research, 08/11/09
Pervanidou P et al. – N–terminal pro–Brain Natriuretic Peptide (NT–proBNP) is an established biomarker for heart failure in adults, while its plasma concentrations are altered in adult obesity. Plasma adiponectin concentrations are decreased in obesity and low levels are associated with disorders with an increased cardiometabolic risk.
Related Articles
Obesity, intentional weight loss and physical disability in older adults
Obesity Reviews, 11/18/09
Relevance Score: 94%
Early life influences on obesity risk: maternal overnutrition and programming of obesity
Expert Review of Endocrinology & Metabolism, 11/12/09
Relevance Score: 94%
Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
Amylin Pharmaceuticals, 10/20/09
Relevance Score: 94%
Obesity as a disease state: A new paradigm for diagnosis and treatment
Clinical Cornerstone, 10/21/09
Relevance Score: 93%
Obesity as a Social Problem in the United States
Policy, Politics, & Nursing Practice, 10/01/09
Relevance Score: 93%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Neuroendocrine carcinomas arising in solid-organ transplant recipients: rare but aggressive malignancies
Oncology (Karger), 11/25/09
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines
Neuroendocrinology, 11/24/09
Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


